Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections: protocol for a cluster-randomized controlled trial
Frontiers in Public Health · 10.03.2026 · 14
DOI: 10.3389/fpubh.2026.1742217 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Public Health, online erschienen am 10.03.2026. Verfasst von Jiali Zhang und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Infections, Pharmacists, Respiratory Tract Infections. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Overuse of antibiotics among patients with upper respiratory tract infections (URTIs) is a worldwide problem. In China, approximately 70% of outpatients with URTIs are treated with antibiotics, often via intravenous infusion. This study aimed to evaluate whether a pharmacist-led multidimensional intervention reduces the use of intravenous (IV) antibacterial drug infusion among patients with bacterial URTIs. Methods and analysis This study employed a pragmatic, parallel controlled, cluster-randomized superiority trial design. Outcome assessment and data analysis were conducted in a blinded manner, while treatment administration remained unblinded. A total of 28 hospitals in Zhejiang Province, China, were randomly allocated in a 1:1 ratio. In the intervention arm, a multidimensional intervention embedded in routine emergency treatment will be applied, involving both doctors and patients. The interventions included systematic physician training, clinical decision support cards, and printed educational materials for patients. Patients admitted to the sites assigned to the control arm will receive usual care at the discretion of treating physicians. The primary outcome was the rate of intravenous antibacterial drug infusion during the index admission. Secondary outcomes included the duration of URTI symptoms, adverse events, proportion of eligible patients who received subsequent antibiotics, frequency of re-consultation, and hospitalization within the follow-up period. The final follow-up was completed by 14 days post-discharge. Participants will be included from August 1, 2025, to January 31, 2026.
Conclusion
This study will demonstrate the feasibility and potential impact of a pharmacist-led, multidimensional intervention aimed at reducing IV antimicrobial use in patients with bacterial URTIs. Clinical trial registration ClinicalTrials.gov , identifier NCT06620341.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou, China.
- Department of Pharmacy, Sheng Zhou Hospital of Traditional Chinese Medicine, Shaoxing, China.
- Department of Pharmacy, The Affiliated Yangming Hospital of Ningbo University, Ningbo, China.
- Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, China.
- Department of Pharmacy, The First People's Hospital of Lin'an District, Hangzhou, China.
Zitieren
APA
Zhang, J., Lou, S. G., Chu, J., Zhang, L., Wu, Q., Xu, Y., Dong, Y., Hu, T., Huo, M., Yan, P., Shao, R., Zhou, J., Zhan, Z., Zhang, M., Ji, C., Lin, L., Wang, J., Zhou, S., He, M., …, & Dai, H. (2026). Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections: protocol for a cluster-randomized controlled trial. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1742217
Vancouver
Zhang J, Lou SG, Chu J, Zhang L, Wu Q, Xu Y, et al. Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections: protocol for a cluster-randomized controlled trial. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1742217
BibTeX
@article{Zhang2026,
author = {Zhang, Jiali and Lou, Song-Gao and Chu, Jianbo and Zhang, Lingdi and Wu, Qihan and Xu, Yanyan and Dong, Yu and Hu, Taotao and Huo, Meng and Yan, Ping and Shao, Rui and Zhou, Jiefang and Zhan, Zhouhong and Zhang, Mengdi and Ji, Chaofeng and Lin, Lisha and Wang, Jinming and Zhou, Shuangshuang and He, Min and Deng, Liping and Ke, Jianghuan and Wang, Jianan and He, Junhong and Chen, Jie and Wang, Shengjiang and Rui, Zhuanghua and Yang, Tongtong and Huang, Yuye and Zhang, Yue and Ke, Lu and Chen, Tao and Jiang, Huifang and Chen, Meng and Hu, Yangmin and Dai, Haibin},
title = {Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections: protocol for a cluster-randomized controlled trial},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1742217}
}
EUVIMED